This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Galena Biopharma Inc (GALE)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -76.68M -34.97M -11.48M -11.99M
Operating Gains/Losses -3.91M 0.00 907.00K 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -3.68M 0.00 0.00 0.00
(Increase) Decrease in Inventories -386.00K 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 684.00K 641.00K 500.00K 99.00K
(Decrease) Increase In Other Current Liabilities 6.73M -139.00K 1.34M 243.00K
(Increase) Decrease In Other Working Capital 0.00 0.00 717.00K 0.00
Other Non-Cash Items 47.67M 14.90M -6.81M 1.25M
Net Cash From Continuing Operations -28.91M -20.96M -14.67M -10.26M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -28.91M -20.96M -14.67M -10.26M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 3.91M 0.00 0.00 5.99M
Purchases of Property, Plant & Equipment -15.85M 0.00 -53.00K -106.00K
Acquisitions 0.00 0.00 168.00K 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 -5.99M
Other Cash from Investing Activities -99.00K -87.00K -101.00K 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -12.04M -87.00K 14.00K -106.00K
Issuance of Debt 0.00 500.00K 500.00K 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 8.54M 42.20M 18.78M 254.00K
Repayment of Long-Term Debt -25.00K -10.00K -84.00K -70.00K
Repurchase of Capital Stock 0.00 -266.00K 0.00 -3.85M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 47.40M 0.00 0.00 15.24M
Net Cash From Financing Activities 55.92M 42.42M 19.20M 11.57M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 14.98M 21.37M 4.54M 1.21M
GALE News

GALE Galena Biopharma Inc

Analysts Ratings for GALE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 5
Moderate Buy 1 1 1 1
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET GALE ANALYST REPORT

Brokerage Partners

GALE Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs